Health and Healthcare

Valeant CEO Takes Temporary Leave on Health Scare

Thinkstock

Valeant Pharmaceuticals International Inc. (NYSE: VRX) watched its shares move lower in Monday’s trading session on a health scare from one of its top executives. Chief Executive Officer J. Michael Pearson, was hospitalized over the Christmas holiday with a severe case of pneumonia.

In response to this sudden occurrence, Valeant’s board of directors created an interim office for the CEO position, which includes Valeant General Counsel Robert Chai-Onn, Chairman Ari Kellen and Chief Financial Officer Robert Rosiello.

Also, a committee created to oversee and support this CEO office, which includes Lead Independent Director Robert A. Ingram, ValueAct Capital President G. Mason Morfit and former Valeant finance chief Howard B. Schiller.

Ingram commented:

The committee will be working closely with the entire management team to ensure that the company continues to operate normally while Mike focuses on his health. Out of respect, we will be honoring his family’s request for privacy and will not be commenting further on his condition at this time.


Recently, Pearson made a promise to shareholders to provide more transparent data about Valeant’s business. In recent events, the company’s strategy has drawn scrutiny from lawmakers and investors for its use of mail-order pharmacies, price increases and acquisitions for growth.

This company has been a lightning rod for attention following a report from Citron Research, a short selling firm, regarding Valeant’s relationship with Philidor. Since this report, the company has broken ties with Philidor.

Shares of Valeant were trading down 9.5% at $103.33 Monday, with a consensus analyst price target of $161.10 and a 52-week trading range of $69.33 to $263.81.

Take Charge of Your Retirement In Just A Few Minutes (Sponsor)

Retirement planning doesn’t have to feel overwhelming. The key is finding expert guidance—and SmartAsset’s simple quiz makes it easier than ever for you to connect with a vetted financial advisor.

Here’s how it works:

  1. Answer a Few Simple Questions. Tell us a bit about your goals and preferences—it only takes a few minutes!
  2. Get Matched with Vetted Advisors Our smart tool matches you with up to three pre-screened, vetted advisors who serve your area and are held to a fiduciary standard to act in your best interests. Click here to begin
  3. Choose Your  Fit Review their profiles, schedule an introductory call (or meet in person), and select the advisor who feel is right for you.

Why wait? Start building the retirement you’ve always dreamed of. Click here to get started today!

 

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.

AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.